NCT01134341 2019-12-18Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell LymphomaAcrotech Biopharma Inc.Phase 1 Completed34 enrolled
NCT01007448 2019-11-12Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)Bausch Health Americas, Inc.Phase 4 Completed59 enrolled 17 charts
NCT00255801 2018-08-16Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell LymphomaMemorial Sloan Kettering Cancer CenterPhase 2 Completed37 enrolled 9 charts
NCT00178841 2016-02-17Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCLVanderbilt UniversityPhase 2 Completed4 enrolled 5 charts
NCT00306969 2006-03-27Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell LymphomaBoston UniversityPhase 1/2 Completed18 enrolled